209 related articles for article (PubMed ID: 38639435)
1. Comparative Efficacy of Dopamine Partial Agonists by Doses for Treatment-Resistant Depression: A Systematic Review and Dose-Response Model-Based Network Meta-analysis.
Terao I; Kodama W
J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):413-417. PubMed ID: 38639435
[TBL] [Abstract][Full Text] [Related]
2. Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia.
Keks N; Hope J; Schwartz D; McLennan H; Copolov D; Meadows G
CNS Drugs; 2020 May; 34(5):473-507. PubMed ID: 32246399
[TBL] [Abstract][Full Text] [Related]
3. Brexpiprazole: a new leaf on the partial dopamine agonist branch.
Hope J; Castle D; Keks NA
Australas Psychiatry; 2018 Feb; 26(1):92-94. PubMed ID: 29017334
[TBL] [Abstract][Full Text] [Related]
4. Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.
Kishi T; Sakuma K; Nomura I; Matsuda Y; Mishima K; Iwata N
Int J Neuropsychopharmacol; 2019 Nov; 22(11):698-709. PubMed ID: 31350882
[TBL] [Abstract][Full Text] [Related]
5. Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
Mohr P; Masopust J; Kopeček M
Front Psychiatry; 2021; 12():781946. PubMed ID: 35145438
[TBL] [Abstract][Full Text] [Related]
6. Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania.
Vieta E; Sachs G; Chang D; Hellsten J; Brewer C; Peters-Strickland T; Hefting N
J Psychopharmacol; 2021 Aug; 35(8):971-982. PubMed ID: 33691517
[TBL] [Abstract][Full Text] [Related]
7. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.
Demyttenaere K; Detraux J; Racagni G; Vansteelandt K
CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941
[TBL] [Abstract][Full Text] [Related]
8. Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
Ali E; Latif F; Mashkoor Y; Sheikh A; Iqbal A; Owais R; Ahmed J; Naveed S; Moeed A; Ullah I; Mughal S
Asian J Psychiatr; 2024 May; 95():104005. PubMed ID: 38513509
[TBL] [Abstract][Full Text] [Related]
9. Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.
Duric V; Banasr M; Franklin T; Lepack A; Adham N; Kiss B; Gyertyán I; Duman RS
Int J Neuropsychopharmacol; 2017 Oct; 20(10):788-796. PubMed ID: 28531264
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis.
Terao I; Tsuge T; Endo K; Kodama W
J Affect Disord; 2024 Feb; 346():49-56. PubMed ID: 37949235
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study.
Thase ME; Youakim JM; Skuban A; Hobart M; Zhang P; McQuade RD; Nyilas M; Carson WH; Sanchez R; Eriksson H
J Clin Psychiatry; 2015 Sep; 76(9):1232-40. PubMed ID: 26301771
[TBL] [Abstract][Full Text] [Related]
12. Optimal dose of brexpiprazole for augmentation therapy of antidepressant-refractory depression: A systematic review and dose-effect meta-analysis.
Furukawa Y; Oguro S; Obata S; Hamza T; Ostinelli EG; Kasai K
Psychiatry Clin Neurosci; 2022 Sep; 76(9):416-422. PubMed ID: 35716011
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study.
Fava M; Ménard F; Davidsen CK; Baker RA
J Clin Psychiatry; 2016 Dec; 77(12):1695-1701. PubMed ID: 27379823
[TBL] [Abstract][Full Text] [Related]
14. The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.
Citrome L
Int J Clin Pract; 2015 Nov; 69(11):1211-20. PubMed ID: 26477545
[No Abstract] [Full Text] [Related]
15. Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Iwata N
Psychopharmacology (Berl); 2020 May; 237(5):1459-1470. PubMed ID: 32002559
[TBL] [Abstract][Full Text] [Related]
16. Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study.
Zazu L; Morera-Herreras T; Garcia M; Aguirre C; Lertxundi U
Eur Neuropsychopharmacol; 2021 Sep; 50():107-111. PubMed ID: 34082277
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis and review of dopamine agonists in acute episodes of mood disorder: Efficacy and safety.
Romeo B; Blecha L; Locatelli K; Benyamina A; Martelli C
J Psychopharmacol; 2018 Apr; 32(4):385-396. PubMed ID: 29543103
[TBL] [Abstract][Full Text] [Related]
18. Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.
Nuñez NA; Joseph B; Pahwa M; Kumar R; Resendez MG; Prokop LJ; Veldic M; Seshadri A; Biernacka JM; Frye MA; Wang Z; Singh B
J Affect Disord; 2022 Apr; 302():385-400. PubMed ID: 34986373
[TBL] [Abstract][Full Text] [Related]
19. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
[TBL] [Abstract][Full Text] [Related]
20. Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.
Román V; Gyertyán I; Sághy K; Kiss B; Szombathelyi Z
Psychopharmacology (Berl); 2013 Mar; 226(2):285-93. PubMed ID: 23138433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
